Press release
Metagenomic Sequencing Market Forecasted 17.6% Growth Rate, Reaching US$ 7.1 Billion by 2033
The Metagenomic Sequencing Market witnessed a significant global revenue of US$ 1.2 Billion in 2022. It is projected to experience a remarkable growth rate of 17.6% from 2023 to 2033, ultimately reaching a valuation of US$ 7.1 Billion by the conclusion of the forecast period.
The Metagenomic Sequencing Market has emerged as a pivotal player in the genomics landscape, offering a holistic view of microbial communities and their genetic makeup. Metagenomic sequencing involves the analysis of genetic material directly harvested from environmental samples, providing a comprehensive understanding of the diversity and functional potential of microbial ecosystems. This innovative approach has gained significant traction across various industries, including healthcare, environmental monitoring, and agriculture.
Get Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=8782
Market Opportunity:
The Metagenomic Sequencing Market presents a plethora of opportunities driven by the expanding applications of metagenomics across diverse sectors. In healthcare, metagenomic sequencing holds promise for identifying novel pathogens, understanding the human microbiome, and developing targeted therapies. The potential for early detection of diseases and the personalization of treatment plans are areas where the market is poised for substantial growth.
Environmental monitoring is another key opportunity area. Metagenomic sequencing enables the monitoring of microbial communities in soil, water, and air, contributing to the assessment of environmental health and aiding in the identification of potential threats such as emerging pathogens and pollutants. In agriculture, metagenomic sequencing offers insights into soil health, plant-microbe interactions, and the development of sustainable farming practices.
Market Challenges:
The Metagenomic Sequencing Market faces several challenges. One of the primary challenges is the complexity of data analysis and interpretation. The vast amount of genomic data generated from metagenomic studies requires sophisticated bioinformatics tools and expertise, posing a barrier to entry for some researchers and organizations.
Standardization of protocols and methodologies is another challenge. The lack of uniformity in sample collection, DNA extraction, and sequencing techniques can lead to variability in results, hindering the comparability of studies. Additionally, ethical and privacy concerns related to the collection and use of microbial genetic data present challenges that need to be addressed to ensure responsible and transparent practices in the field.
Key Players:
Illumina, Inc.
Thermo Fisher Scientific
QIAGEN
PerkinElmer, Inc.
Oxford Nanopore Technologies Plc.
Pacific Biosciences of California, Inc.
BGI Group
Psamogen, Inc.
Eurofins Scientific
Azenta Life Sciences
Novogen Co. Ltd.
Zymo Research Corporation
Tecan Trading AG
Integragen SA
Microsynth AG
Competitive Landscape:
In July 2021, a strategic collaboration was unveiled as Pacific Biosciences joined forces with Invitae, a prominent player in the realm of medical genetics. This groundbreaking partnership aims to synergize Pacific Biosciences' cutting-edge long-read sequencing technology with Invitae's extensive expertise in clinical genetic testing. The ultimate goal is to forge a high-throughput sequencing platform tailored for genetic testing applications.
Similarly, in February 2021, Thermo Fisher made waves by announcing a collaborative effort with Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. This partnership is focused on the development of a companion diagnostic test for a cancer drug. Thermo Fisher's Next-Generation Sequencing (NGS) technology will take center stage in this initiative, playing a pivotal role in identifying patients likely to respond positively to the targeted drug.
Adding to the dynamic landscape of genomics partnerships, in December 2020, Illumina made a strategic move by acquiring Pacific Biosciences for an approximate sum of US$ 1.2 billion. This acquisition marks a significant milestone, as it brings together the strengths and expertise of both companies in the field of DNA sequencing. The amalgamation is anticipated to foster innovation and advancements, contributing to the evolution of genomic technologies.
Segmentation of the Metagenomic Sequencing Market :
By Product & Service :
Reagents & Consumables
Instruments
Services
Analysis & Data Interpretation Solutions
By Workflow :
Sample Processing & Library Preparation
Sequencing
Data Processing & Analysis
By Technology :
Shotgun Metagenomic Sequencing
16S rRNA Sequencing
Metatranscriptomics
Whole-genome Sequencing & De Novo Assembly
By Application :
Drug Discovery
Clinical Diagnostics
Soil Microbiome Application
Industrial Applications
Energy
Bioremediation
Other
Ecology and Environmental Applications
Veterinary Applications
Other Applications
By Region :
North America
Latin America
Europe
Asia Pacific
Middle East & Africa Top of Form
Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=8782
Contact:
US Sales Office
11140 Rockville Pike
Suite 400 Rockville, MD 20852
United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Sales Team: sales@factmr.com
About Fact.MR :
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
The Metagenomic Sequencing Market has emerged as a pivotal player in the genomics landscape, offering a holistic view of microbial communities and their genetic makeup. Metagenomic sequencing involves the analysis of genetic material directly harvested from environmental samples, providing a comprehensive understanding of the diversity and functional potential of microbial ecosystems. This innovative approach has gained significant traction across various industries, including healthcare, environmental monitoring, and agriculture.
Get Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=8782
Market Opportunity:
The Metagenomic Sequencing Market presents a plethora of opportunities driven by the expanding applications of metagenomics across diverse sectors. In healthcare, metagenomic sequencing holds promise for identifying novel pathogens, understanding the human microbiome, and developing targeted therapies. The potential for early detection of diseases and the personalization of treatment plans are areas where the market is poised for substantial growth.
Environmental monitoring is another key opportunity area. Metagenomic sequencing enables the monitoring of microbial communities in soil, water, and air, contributing to the assessment of environmental health and aiding in the identification of potential threats such as emerging pathogens and pollutants. In agriculture, metagenomic sequencing offers insights into soil health, plant-microbe interactions, and the development of sustainable farming practices.
Market Challenges:
The Metagenomic Sequencing Market faces several challenges. One of the primary challenges is the complexity of data analysis and interpretation. The vast amount of genomic data generated from metagenomic studies requires sophisticated bioinformatics tools and expertise, posing a barrier to entry for some researchers and organizations.
Standardization of protocols and methodologies is another challenge. The lack of uniformity in sample collection, DNA extraction, and sequencing techniques can lead to variability in results, hindering the comparability of studies. Additionally, ethical and privacy concerns related to the collection and use of microbial genetic data present challenges that need to be addressed to ensure responsible and transparent practices in the field.
Key Players:
Illumina, Inc.
Thermo Fisher Scientific
QIAGEN
PerkinElmer, Inc.
Oxford Nanopore Technologies Plc.
Pacific Biosciences of California, Inc.
BGI Group
Psamogen, Inc.
Eurofins Scientific
Azenta Life Sciences
Novogen Co. Ltd.
Zymo Research Corporation
Tecan Trading AG
Integragen SA
Microsynth AG
Competitive Landscape:
In July 2021, a strategic collaboration was unveiled as Pacific Biosciences joined forces with Invitae, a prominent player in the realm of medical genetics. This groundbreaking partnership aims to synergize Pacific Biosciences' cutting-edge long-read sequencing technology with Invitae's extensive expertise in clinical genetic testing. The ultimate goal is to forge a high-throughput sequencing platform tailored for genetic testing applications.
Similarly, in February 2021, Thermo Fisher made waves by announcing a collaborative effort with Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. This partnership is focused on the development of a companion diagnostic test for a cancer drug. Thermo Fisher's Next-Generation Sequencing (NGS) technology will take center stage in this initiative, playing a pivotal role in identifying patients likely to respond positively to the targeted drug.
Adding to the dynamic landscape of genomics partnerships, in December 2020, Illumina made a strategic move by acquiring Pacific Biosciences for an approximate sum of US$ 1.2 billion. This acquisition marks a significant milestone, as it brings together the strengths and expertise of both companies in the field of DNA sequencing. The amalgamation is anticipated to foster innovation and advancements, contributing to the evolution of genomic technologies.
Segmentation of the Metagenomic Sequencing Market :
By Product & Service :
Reagents & Consumables
Instruments
Services
Analysis & Data Interpretation Solutions
By Workflow :
Sample Processing & Library Preparation
Sequencing
Data Processing & Analysis
By Technology :
Shotgun Metagenomic Sequencing
16S rRNA Sequencing
Metatranscriptomics
Whole-genome Sequencing & De Novo Assembly
By Application :
Drug Discovery
Clinical Diagnostics
Soil Microbiome Application
Industrial Applications
Energy
Bioremediation
Other
Ecology and Environmental Applications
Veterinary Applications
Other Applications
By Region :
North America
Latin America
Europe
Asia Pacific
Middle East & Africa Top of Form
Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=8782
Contact:
US Sales Office
11140 Rockville Pike
Suite 400 Rockville, MD 20852
United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Sales Team: sales@factmr.com
About Fact.MR :
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
